Menu Search
Equities

Inspiration Healthcare Group PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
LXD1:STU

Inspiration Healthcare Group PLC

Actions
  • Price (EUR)0.187
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+22.22%
  • Beta1.0586
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Inspiration Healthcare Group plc is a United Kingdom-based global medical technology company providing neonatal intensive care medical devices. The Company provides products to patients around the world which help to improve patient outcomes, whether it is a baby who has been born prematurely, or a patient undergoing surgery. Its areas of care include Acute Care and Infusion Therapies. Its Acute Care products include neonatal, respiratory, auto FiO2, obstetrics and developmental care. It offers a full range of ambulatory infusion pumps, administration sets, accessories, and patient infusion management systems for both hospital and homecare applications. It provides a range of Micrel Medical infusion devices, for various applications such as parenteral nutrition, oncology, immunoglobulin therapy, antibiotic infusion, palliative care, acute pain management, and obstetrics. It is also a manufacturer of specialist pneumatic oxygen-powered life support ventilators.

  • Revenue in GBP (TTM)45.20m
  • Net income in GBP-11.44m
  • Incorporated1998
  • Employees214.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.